Home » Topics » Disease categories and therapies » Urology

Urology
RSS

Positive interim data reported for PRX-302

Oct. 9, 2007

FDA special protocol assessment assigned to atacicept pivotal trial

Oct. 8, 2007

Novel tachykinin NK1 receptor antagonists emerge from Tanabe Seiyaku R&D

Oct. 1, 2007

Keryx sells Zerenex licensing to JT and Torii for development and marketing in Japan

Oct. 1, 2007

NexMed files NDA for topically applied alprostadil cream

Sep. 28, 2007

Recordati completes double-blind portion of phase III Urief trial for BPH

Sep. 28, 2007

Allergan to acquire Esprit Pharma and partner with Indevus on Sanctura brand

Sep. 21, 2007

Palatin reacquires full rights to bremelanotide program

Sep. 13, 2007

Positive results for Plethora Solutions' phase II study of PSD-597 for interstitial cystitis

Sep. 10, 2007

Novel ATP-sensitive potassium channel activators emerge from Janssen R&D

Sep. 6, 2007

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 2, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 2, 2026
ASCO 2026: A revolution in pancreatic cancer
BioWorld
At the 2026 American Society of Clinical Oncology (ASCO) Annual Meeting, Revolution Medicines Inc. followed up its stellar top-line data with the details from the...
BMS’ mezigdomide doubles PFS in multiple myeloma
BioWorld
Bristol Myers Squibb Co. disclosed in March 2026 that the phase III portion of the seamless phase II/III Successor-2 study testing mezigdomide in combination with...
ADCs, multispecific antibodies anchor $10B Pfizer-Innovent deal
BioWorld
Pfizer Inc. is paying Innovent Biologics Co. Ltd. $650 million up front and up to $9.85 billion in milestones, plus royalties, to collaborate across 12 early...